Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes

OBJECTIVES: We compared the treatment effectiveness between guselkumab and adalimumab in patients with pustulotic arthro-osteitis (PAO). In addition, we performed peripheral blood immunophenotyping to elucidate the immunological background and analyzed the impact of therapeutic drugs to verify the v...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Masanobu, Miyagawa, Ippei, Miyazaki, Yusuke, Hanami, Kentaro, Fukuyo, Shunsuke, Kubo, Satoshi, Nakayamada, Shingo, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609190/
https://www.ncbi.nlm.nih.gov/pubmed/36303202
http://dx.doi.org/10.1186/s13075-022-02934-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609190/
https://www.ncbi.nlm.nih.gov/pubmed/36303202
http://dx.doi.org/10.1186/s13075-022-02934-3

Ejemplares similares